The far-right Alternative for Germany (AfD) on Saturday drew ahead of Chancellor Friedrich Merz's conservatives in a new opinion poll.
Merz's Christian Democratic Union (CDU) and its Bavarian sister party, the Christian Social Union (CSU), dropped by one percentage point to 25% in the INSA poll for the Sunday edition of the Bild newspaper.
The AfD, Germany's largest opposition party, was unchanged from last week's survey on 26%. The anti-immigrant party is under investigation by domestic intelligence services for its extremist views, but surged to second place in the 2025 parliamentary election.
In third place were Merz's centre-left coalition partners in the Social Democratic Party (SPD), down one point to 13%.
The opposition Greens and The Left were also unchanged at 12% and 11% respectively.
The margin of error was 2.9 percentage points, with 1,199 respondents participating in the survey.
latest_posts
- 1
Figure out How to Introduce Sunlight powered chargers on Your Rooftop securely - 2Flights canceled at 40 U.S. airports: Follow live updates as FAA cuts to air traffic take effect amid government shutdown
- 3Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out
- 4An eye for an eye: People agree about the values of body parts across cultures and eras
- 51,000-mile Saharan dust storm, from the sky and from the ground
- Instructions to Pick the Right Toothpaste for Your Dental Requirements
- Turning to turkey’s tryptophan to boost mood? Not so fast
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
- U.K. blocks Kanye West from entering Britain to headline now canceled festival: What led to the ban
- The most effective method to Explore Moral Situations in Brain research with Your Certification
- Sustaining Public activity and Connections: Key Methodologies
- Grass Care Administrations for a Wonderful, Sound Yard
- Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
